back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-09-29 08:50 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$55,001
+18,457 vol $2.98 each |
29,610 | |
| Filed 2025-09-29 08:49 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,457 vol |
32,596 | |
| Filed 2025-09-29 08:48 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-20,649 vol |
51,053 | |
| Filed 2025-09-29 08:48 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+32,596 vol |
71,702 | |
| Filed 2024-12-10 16:10 Tx date 2024-09-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+39,106 vol |
53,874 | |
| Filed 2024-09-30 16:17 Tx date 2024-09-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$27,101
+11,153 vol $2.43 each |
11,153 | |
| Filed 2024-09-30 16:16 Tx date 2023-09-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-30 16:16 Tx date 2024-09-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-14,768 vol |
0 | |
| Filed 2023-10-03 17:09 Tx date 2023-09-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+14,768 vol |
14,768 | |
| Filed 2023-10-03 17:08 Tx date 2023-09-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|